D. van der Heijde
- Rheumatology top 0.2%
- Immunology top 2%
- Hematology top 1%
- Molecular Biology
- Orthopedics and Sports Medicine top 2%
- Co-authors
- Carine SalliotRobert LandewéNaoki NishimotoTsutomu TakeuchiShinichi KawaiJun HashimotoN. MiyasakaTadamitsu Kishimoto
- Topics
- Rheumatoid Arthritis Research and Therapies (41 papers)Spondyloarthritis Studies and Treatments (26 papers)Autoimmune and Inflammatory Disorders Research (14 papers)
- Cited by
- RheumatologyHematologyImmunology
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
D. van der Heijde
55 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Rheumatology 2.4k
- Immunology 955
- Hematology 951
- Molecular Biology 302
- Orthopedics and Sports Medicine 266
Countries citing papers authored by D. van der Heijde
This map shows the geographic impact of D. van der Heijde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. van der Heijde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. van der Heijde more than expected).
Fields of papers citing papers by D. van der Heijde
This network shows the impact of papers produced by D. van der Heijde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. van der Heijde. The network helps show where D. van der Heijde may publish in the future.
Co-authorship network of co-authors of D. van der Heijde
This figure shows the co-authorship network connecting the top 25 collaborators of D. van der Heijde. A scholar is included among the top collaborators of D. van der Heijde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. van der Heijde. D. van der Heijde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Discontinuation of Tumor Necrosis Factor Inhibitor Therapy in US Patients with Ankylosing Spondylitis : Data from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry | 1 |
| 2 | CERTOLIZUMAB PEGOL FOR THE TREATMENT OF PSORIATIC ARTHRITIS: 4-YEAR OUTCOMES FROM THE RAPID-PSA TRIAL | 2 |
| 3 | Pharmacological Treatment of Psoriatic Arthritis (PSA): Systematic Literature Review for the Update of the EULAR Recommendations for the Management of PSA | 1 |
| 4 | Oskira-1: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Methotrexate | 7 |
| 5 | 60 | |
| 6 | Tofacitinib, an Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: Year 2 Efficacy and Safety Results From a 24-Month Phase 3 Study | 4 |
| 7 | Improvement in Physical Function, Health-Related Quality of Life, and Work Productivity with Adalimumab Treatment in Nonradiographic Axial Spa: Wk-52 Results From Ability-1 | 1 |
| 8 | DISEASE BURDEN IS COMPARABLE IN NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AND ANKLOYSING SPONDYLITIS PATIENTS : TREATMENT IMPLICATIONS | 1 |
| 9 | 24 | |
| 10 | EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS : 3-YEAR DATA FROM THE RAPID 2 STUDY | 2 |
| 11 | RADIOGRAPHIC FINDINGS AFTER 5 YEARS OF INFLIXIMAB TREATMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS | 1 |
| 12 | 88 | |
| 13 | Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature researchbreakdown → | 487 |
| 14 | 67 | |
| 15 | 49 | |
| 16 | Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanerceptbreakdown → | 408 |
| 17 | 124 | |
| 18 | Infliximab therapy leads to clinical and radiographic benefits in early rheumatoid arthritis patients receiving optimum methotrexate dose | 4 |
| 19 | The effect of infliximab therapy on the prevention of new erosions in patients with early rheumatoid arthritis. | 2 |
| 20 | 17 |
About D. van der Heijde
D. van der Heijde is a scholar working on Rheumatology, Hematology and Immunology, having authored 58 papers that have together received 2.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (41 papers), Spondyloarthritis Studies and Treatments (26 papers) and Autoimmune and Inflammatory Disorders Research (14 papers). The work is most often cited by research in Rheumatology (2.4k citations), Hematology (951 citations) and Immunology (955 citations). D. van der Heijde has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Carine Salliot, Robert Landewé, Naoki Nishimoto, Tsutomu Takeuchi, Shinichi Kawai, Jun Hashimoto, N. Miyasaka, Tadamitsu Kishimoto, N. Murata and Kazuhiko Yamamoto. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and RMD Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.